Furthermore, systemic administration of a specific NK1R antagonist (L703,606) significantly reduced CNS gliosis, demyelination, and associated inflammatory cytokine elevations in murine models of bacterial meningitis [11]. This evidence concerns the gene TACR1 and bacterial meningitis.